Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s): QNTM

Healthcare Biotechnology

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

CSE:QNTM - Post by User

Quantum BioPharma Ltd > I expect to see additional IND's for MS and Major Depression

<< Previous

Bullboard Posts

Next >>

Comment by JensLenson May 31, 2022 10:20am

79 Views

Post# 34719849

RE:RE:I expect to see additional IND's for MS and Major Depression

Mil_Man54 wrote: You have some insoder information pumper....car to share since you get compensated to pump this POS.

Nobody is compensated , I am compensated only one way , and if that stock price goes up if they can prove good results from the trials etc

another right move by FSD Pharma after IND is submitted and if they are approved then they can start trials for the infalmmation indiction.

I expect more IND for MS and depression

we got the phase 2 covered now for PEA

<< Previous

Bullboard Posts

Next >>

Global Tungsten Market and Supply Security